SCHEMBL4879199

SCHEMBL4879199

CC(C)OC(=O)Nc1cc(F)c(/C=C/C(=O)O)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
HPGD P15428 2/20 0.43
ALOX15 P16050 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.42
CASP3 P42574 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
EGFR P00533 2/20 0.36
MMP12 P39900 2/20 0.35
MMP13 P45452 2/20 0.35
MIF P14174 1/20 0.34
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4879206 1.00 KDM4E (0.43) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL5379512 0.88 HPGD (0.44) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL4873394 0.84 KDM4E (0.44) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL4882291 0.82 KDM4E (0.48) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL4875726 0.82 KDM4E (0.43) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL4875742 0.82 KDM4E (0.43) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL5379517 0.80 KDM4E (0.43) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL5379521 0.80 KDM4E (0.43) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL6244428 0.78 KDM4E (0.49) KDM4EHPGDALOX15SMN1; SMN2NPC1
SCHEMBL5374821 0.74 MGLL (0.52) SMN1; SMN2NPC1RAB9AALDH1A1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 KDM4E 3740/4885HPGD 473/4885ALOX15 2538/4885
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES OXA1L, CYP51A1, CYP2C19 KDM4E 3561/4885HPGD 467/4885ALOX15 2603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.